Skip to main content

Table 1 The correlation between ARHGAP11A expression and clinicopathological characteristics in HCC patients

From: Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma

Clinicopathological variables ARHGAP11A expression P value χ2
High Low
Gender    P > 0.05 0.3
 Male 33 29   
 Female 8 5   
Age    P > 0.05 0.574
  < 45 y 18 12   
  ≥ 45 y 23 22   
Maximal tumor size    P < 0.05 4.467
  ≤ 5 cm 19 24   
  > 5 cm 22 10   
Tumor differentiation    P < 0.05 10.941
 I-II 20 29   
 III-IV 21 5   
Serum AFP    P > 0.05 0.313
  ≤ 400 (ng/ml) 12 8   
 > 400 (ng/ml) 29 26   
Metastasis    P < 0.05 3.969
 No 30 31   
 Yes 11 3   
TNM stage    P < 0.001 17.844
 I-II 9 24   
 III 32 10   
  1. Statistically significant (P < 0.05)